Alzoughool et al. [39], in turn, suggested the combined use of CRP and D-dimer, proposing that a sixfold increase in both may indicate a greater propensity to develop severe cerebrovascular complications in COVID-19, such as stroke. This evidence concerns the gene CRP and stroke disorder.